Popular Eli Lilly weight-loss drug Zepbound can be covered by Medicare plans to treat sleep apnea after it received Food and ...

Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Adam Maeder, an analyst from Piper Sandler, has initiated a new Hold rating on Resmed (RMD).Stay Ahead of the Market:Discover outperforming ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

PROVIGIL and NUVIGIL become the latest branded medicines to be sold in the United States within the Apotex Group's diversified global portfolio of products.

Research suggests the benefits of testosterone therapy after prostate cancer surgery in select men may outweigh risks.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

Investment analysts at Zacks Research reduced their FY2024 earnings estimates for shares of Axsome Therapeutics in a research ...

When it comes to health foods, cheese is a champ. For starters, dietary gurus have decreed that unlike the mostly saturated ...

Performance Home Medical plans to use an additional $55 million investment from Grant Avenue Capital to shift its business ...

After one month, the study participants had their sleep assessed according to the Pittsburgh Sleep Quality Index. Those who ...